Clinical trials
Phase 3 Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Terminated | 12 |
| Active, not recruiting | 11 |
| Recruiting | 9 |
| Unknown status | 7 |
| Withdrawn | 4 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 10 |
| Novartis Pharmaceuticals | 5 |
| Merck Sharp & Dohme LLC | 4 |
| National Cancer Institute (NCI) | 3 |
| Pfizer | 3 |
| Steba Biotech S.A. | 3 |
| Australasian Gastro-Intestinal Trials Group | 2 |
| Daiichi Sankyo | 2 |
| Exelixis | 2 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 76 |
| Neoplasms | 24 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Neoplasm Metastasis | 12 |
| Lung Neoplasms | 9 |
| Neoplasms by Site | 9 |
| Adenocarcinoma | 8 |
| Carcinoma, Squamous Cell | 7 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Carcinoma, Hepatocellular | 6 |
Trials
Showing 76 to 76 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.